Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02073487
Title Neoadjuvant TDM1 With Lapatinib and Abraxane Compared With Trastuzumab With Lapatinib and Paclitaxel
Acronym TEAL
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors The Methodist Hospital System
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Houston Methodist Hospital Houston Texas 77030 United States Details
Houston Methodist Hospital Willowbrook Houston Texas 77070 United States Details
Houston Methodist Hospital Sugar Land Sugar Land Texas 77479 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field